ABSTRACT
Legionella pneumophila promotes its survival and replication in phagocytes by actively modulating cellular processes using effectors injected into host cells by its Dot/Icm type IV secretion system. Many of these effectors function to manipulate the ubiquitin network of infected cells, thus contributing to the biogenesis of the Legionella-containing vacuole (LCV), which is permissive for bacterial replication. Among these, members of the SidE effector family (SidEs) catalyze ubiquitination of functionally diverse host proteins by a mechanism that is chemically distinct from the canonical three-enzyme cascade. The activity of SidEs is regulated by two mechanisms: reversal of the phosphoribosyl ubiquitination by DupA and DupB and direct inactivation by SidJ, which is a calmodulin-dependent glutamylase. In many L. pneumophila strains, SidJ belongs to a two-member protein family. Its homolog SdjA appears to function differently from SidJ despite the high-level similarity in their primary sequences. Here, we found that SdjA is a bifunctional enzyme that exhibits distinct activities toward members of the SidE family. It inhibits the activity of SdeB and SdeC by glutamylation. Unexpectedly, it also functions as a deglutamylase that reverses SidJ-induced glutamylation on SdeA. Our results reveal that an enzyme can catalyze two completely opposite biochemical reactions, which highlights the distinct regulation of phosphoribosyl ubiquitination by the SidJ effector family.
KEYWORDS: type IV secretion, bacterial virulence, deglutamylase, glutamylation
INTRODUCTION
Intracellular bacterial pathogens have evolved effective mechanisms to maintain the integrity of host cells, which is essential for their success in colonization. One commonly used mechanism is to repress the expression of key virulence factors once the pathogen has been phagocytosed by host cells. A prominent example is the repression of genes involved in flagellum biogenesis by Salmonella enterica serovar Typhimurium and Legionella pneumophila after entering host cells (1, 2). This regulation is necessary because components of flagella are potent immune ligands detectable by intracellular receptors (3). Regulation of gene expression is often complemented by more subtle and specific mechanisms involved in the use of one virulence factor to regulate the activity of another virulence factor whose activity may damage host cells if left uncontrolled. For example, during its entry into nonphagocytic cells, S. enterica Typhimurium utilizes the guanine nucleotide exchange factor (GEF) SopE to activate Rac1 and CDC42, whose activity is antagonized by the GTPase activation protein (GAP) SptP, leading to restoration of host actin cytoskeleton after successful invasion (4).
To create the Legionella-containing vacuole (LCV) permissive for its intracellular replication, L. pneumophila modulates the function of a number of cellular processes by effectors injected into host cells by its Dot/Icm secretion system (5). Not surprisingly, branches of vesicle trafficking are targeted by cohorts of effectors of this intravacuolar pathogen. Rab1, a key regulator of the anterograde transport between the endoplasmic reticulum (ER) and the cis-Golgi compartment, is hijacked by SidM/DrrA, LepB, SidD, AnkX, and Lem3, which spatially and temporally regulate its activity by distinct biochemical activities (3, 6–9). Arf1, the regulator for retrograde trafficking between these two organelles is co-opted by the bacterial GEF RalF (10). The control of retromer transport and the endosomal network is imposed by effectors such as RidL and VipD, which target Vps29 and phosphatidylinositol 3-phosphate on endosomes, respectively (11–13). Furthermore, it has been shown that the actin cytoskeleton is modulated by the actin nucleator VipA (14), the protease RavK, which cleaves actin (15), and the phosphatase WipA and kinase LegK2, which target the ARP2/3 complex (16, 17). In some cases, a group of effectors coordinate to regulate a cellular event important for the biogenesis of the LCV. For example, the enrichment of phosphatidylinositol 4-phosphate [PI(4)P] on the LCV is largely attributed to a catalytic cascade composed of MavQ, LepB, and SidF, which function as phosphatidylinositide 3-kinase (18, 19), phosphatidylinositide 4-kinase (20), and phosphatidylinositol-3-phosphatase (21), respectively, to synthesize this lipid from phosphatidylinositol. PI(4)P functions as the anchor for a number of effectors, including the E3 ubiquitin ligases SidC and SdcA (22) and the multifunctional protein SidM (23). In addition, the enrichment of PI(4)P on the LCV makes the lipid composition of its membrane resemble that of the cis-Golgi compartment, which may facilitate the interception of vesicles originating from the ER (24). Finally, more than 20 effectors have been shown to hijack the ubiquitin network of host cells by diverse mechanisms. At least 12 effectors function as E3 ubiquitin ligases that cooperate with host E1 and E2 enzymes to modify host and, in some cases, bacterial proteins (25). Several effectors catalyze atypical ubiquitination by mechanisms differing from the canonical three-enzyme cascade (26, 27). Multiple deubiquitinases that hydrolyze an array of different polyubiquitin chains have also been described (28). The use of a large panel of effectors to usurp the host ubiquitin network highlights the importance of ubiquitin signaling in the intracellular life cycle of L. pneumophila.
One unique feature associated with Dot/Icm substrates is the existence of closely similar homologs that form distinct protein families (29). For example, SidC and SdcA share 72% identity and 82% similarity in their primary sequences (29), and both are E3 ubiquitin ligases that modify such proteins as the small GTPase Rab10 (30, 31). Similarly, members of the SidE family catalyze phosphoribosyl ubiquitination of a similar substrate pool by an ADP-ribosylation mechanism induced by a mono-ADP-ribosyltransferase (mART) motif (26, 32). SidE-induced ubiquitination of Rab33b leads to its association with the ER by hijacking Golgi-to-ER retrograde trafficking (33). Given the high-level similarity in their primary sequences, it is not surprising that members of these effector families exhibit almost identical activity. Interestingly, contrary to the conventional view that structurally similar proteins often share common activity, a few recent studies found that highly homologous proteins can perform completely opposite biochemical functions. For example, MavC and MvcA share 62% similarity in their primary sequences, their structures are almost superimposable, and both are capable of deamidating ubiquitin at Gln40 (34). However, these two proteins regulate the activity of the E2 enzyme UBE2N by opposite biochemical activities. Whereas MavC inhibits UBE2N function by catalyzing an atypical monoubiquitination that covalently attaches ubiquitin to Lys82 of UBE2N (27), MvcA antagonizes the inhibition by reversing the modification (35). Similarly, domains conferring phosphodiesterase (PDE) activity in SidE, SdeA, SdeB, and SdeC function to cleave a phosphodiester bond in the reaction intermediate ADP-ribosyl ubiquitin (ADPR-Ub) and attach phosphoribosyl ubiquitin to serine residues of substrate proteins (32, 36). However, structurally similar PDE domains in DupA (also known as SdeD [29]) and DupB function to remove phosphoribosyl ubiquitin from modified proteins (37, 38).
In addition to DupA and DupB, which reverse phosphoribosyl ubiquitination, the activity of the SidEs is regulated by SidJ, a glutamylase that is activated by the eukaryotic protein calmodulin (CaM). Activated SidJ inhibits the ADP-ribosyltransferase activity of SidEs by covalently attaching one or more glutamate moieties on the first glutamate residue of the ExE (where “x” represents any amino acid) element of the mART motif that is essential for ubiquitin activation (39–42). Interestingly, in L. pneumophila strains such as Philadelphia 1, SidJ is one member of a family consisting of two proteins (43). Despite the high-level similarity (57% identity; 74% similarity) between SidJ and SdjA(Lpg2508), the latter cannot suppress the yeast toxicity of SdeA (44). In this study, we set out to determine the function of SdjA by examining its impact on the activity of members of the SidE family. Our results reveal that SdjA is a bifunctional enzyme that exhibits distinctly different activities toward members of the SidE family.
RESULTS
SdjA distinctively regulates the activity of the SidE family effectors.
Members of the SidE effector family (SidE, SdeA, SdeB, and SdeC) utilize identical biochemical mechanisms to catalyze phosphoribosyl ubiquitination of a large pool of substrates, ranging from Rab small GTPases to reticulons that are involved in ER structure (26, 32). The activity of these ubiquitin ligases is inhibited by SidJ, a calmodulin-dependent glutamylase that catalyzes polyglutamylation on one of the catalytic glutamate residues of their mART motif (39–42). On the chromosome of the Philadelphia 1 strain, while sidJ is localized between sdeB and dupA, which codes for one of the deubiquitinases that function to remove phosphoribosyl ubiquitin from modified substrates, sdjA is situated next to dupB, which is functionally equivalent to dupA (37, 38) (Fig. 1A). Paradoxically, despite sharing 74% similarity in their primary sequences (Fig. S1), SidJ and SdjA seem to differ in their activity, as SdjA is unable to suppress the yeast toxicity of SdeA (44).
To determine the function of SdjA, we first examined whether this protein is made by L. pneumophila. Using polyclonal antibodies specific for SdjA, we probed its expression in bacteria grown at different phases in buffered yeast extract medium and found that SdjA is expressed at similar levels throughout the growth cycle (Fig. 1B). This expression pattern is similar to that of its homolog SidJ (43), suggesting that both SdjA and SidJ are made and translocated into host cells likely during the entire intracellular life cycle of L. pneumophila.
The requirement of CaM for the glutamylase activity of SidJ predicts that expression of this cofactor in L. pneumophila inactivates endogenous SidEs and phenocopies the ΔsidE mutant in intracellular replication (26, 45). Indeed, wild-type L. pneumophila harboring a plasmid expressing CaM displayed a significant growth defect in Dictyostelium discoideum (Fig. 1C). This defect was less severe than that in the ΔsidE mutant (lacking all members of the SidE family) (Fig. 1C), suggesting that a portion of proteins of the SidE family remain active. Furthermore, whereas robust ubiquitination of Rab33b occurred in cells infected with the wild-type strain, such modification became undetectable in samples infected with the strain expressing CaM (Fig. 1D and E).
Unlike its ortholog sidJ, deletion of sdjA does not affect intracellular bacterial replication (43); we therefore examined its impact on the activity of SidEs by expressing CaM in the ΔsidJ mutant. As expected, intracellular growth of the ΔsidJ ΔsdjA(pCaM) strain was similar to that of the ΔsidJ(pCaM) strain; both were slightly defective (Fig. 1C). Because sidJ is required for maximal intracellular growth (43), it is difficult to distinguish the exact factors directly responsible for the defects observed in the ΔsidJ(pCaM) strain. We thus examined SidEs-induced ubiquitination of Rab33b by these L. pneumophila strains. Compared to samples infected with the wild-type strain expressing CaM, the amount of ubiquitinated Rab33b markedly increased in cells infected with the ΔsidJ(pCaM) strain and further increased in cells with the ΔsidJ ΔsdjA(pCaM) strain (Fig. 1D and E). These results suggest that endogenous SdjA inhibits the activity of a fraction of SidE family proteins or only some of its members.
We further examined the impact of SdjA on members of the SidE family by coexpressing CaM with SdeA or SdeC in the ΔsidE ΔsidJ strain. As expected, introduction of a SdeA-expressing plasmid into this mutant restored its ability to ubiquitinate Rab33b and coexpression of CaM did not affect such modification (Fig. 1F, strains 2 and 3). This result is consistent with the notion that SdjA cannot inactivate SdeA even in the presence of CaM. In contrast, whereas introduction of SdeC can similarly restore the ability of the ΔsidE ΔsidJ strain to ubiquitinate Rab33b, coexpression of CaM led to abolishment of such modification (Fig. 1F, strains 4 and 5). The expression and translocation of SdeA, SdeC, or SdjA was similar among the relevant L. pneumophila strains (Fig. 1F, bottom), indicating that the change in the function of SdeC likely is caused by the activity of SdjA.
SdjA selectively suppresses the yeast toxicity of members of the SidE family.
Unlike SidJ, which effectively suppresses yeast toxicity of each member of the SidE family (46), SdjA was unable to alleviate the toxicity of SdeA (44). The phenotypes associated with L. pneumophila strains expressing CaM suggest that SdjA differently impacts the activity of members of the SidE family (Fig. 1F); we therefore further analyzed such differences by determining its ability to counteract the yeast toxicity of each SidE family member. Consistent with the results from L. pneumophila strains expressing CaM, SdjA effectively suppressed the yeast toxicity caused by SdeB or SdeC. In contrast, although expressed at similar levels, SdjA cannot rescue the growth of strains expressing SidE or SdeA (Fig. 2). These results further support the notion that SdjA differently impacts the activity of members of the SidE family.
SdjA inhibits the ubiquitin ligase activity of SdeB and SdeC but not SidE and SdeA.
Members of the SidE family induce ubiquitination in which ubiquitin is covalently linked to a protein substrate via Arg42 through a phosphoribosyl moiety (32, 36). To determine how SdjA impacts the function of these ubiquitin ligases, we coexpressed in mammalian cells each of them with SdjA and HA-Ub-AA, a ubiquitin mutant in which the two carboxyl-terminal glycine residues have been replaced with alanine. HA-Ub-AA can be used only by SidEs, not by enzymes of the canonical ubiquitination machinery, thus reducing background ubiquitination when probed with the HA antibody. With the exception of SidE, which exhibited considerably lower activity, expression of Ub-AA with SdeA, SdeB, or SdeC led to robust ubiquitination by HA-Ub-AA (Fig. 3A). When SdjA was coexpressed, modification by Ub-AA induced by SidE or SdeA was not detectably decreased. In contrast, in experiments with SdeB or SdeC, coexpression of SdjA drastically reduced the amounts of modified proteins (Fig. 3A). We further examined the differential impact of SdjA on these ubiquitin ligases by testing the modification of Rab33b. Consistent with the results from probing ubiquitination in total proteins, SdjA interferes with Rab33b ubiquitination induced by SdeB or SdeC but not by SidE or SdeA (Fig. 3B).
SidJ exerts its inhibitory effect on the activity of SidEs by catalyzing covalent attachment of one or more glutamate residues onto a glutamate critical for NAD binding in the mART motif (39–42). We thus examined whether the mART domain in these ubiquitin ligases is sufficient to allow the selective inhibition imposed by SdjA. Because the mART domains from SdeB and SdeC are virtually identical (differing by only one residue) (Fig. S2), we used the one from SdeB(541–886) along with those from SidE(554–898) and SdeA(556–903) in our experiments. Each of these three mART domains was coexpressed with SdjA or SidJ in mammalian cells, and the corresponding mART-containing proteins isolated by immunoprecipitation were incubated with a reaction cocktail that allows Rab33b ubiquitination (Fig. 3C). In each case, the mART domain that never encountered SidJ or SdjA robustly induced Rab33b ubiquitination. In contrast, all mART domains coexpressed with SidJ lost the activity (Fig. 3D and E). While the mART domain of SdeB coexpressed with SdjA lost the ability to induce Rab33b ubiquitination, similarly prepared mART domains from SidE and SdeA maintained robust activity (Fig. 3D and E). Thus, the mART domains of SdeA and SdeB have sufficient variations to confer the distinct responses to the activity of SdjA.
SdjA is a CaM-dependent glutamylase against SdeB and SdeC.
The inhibitory effect of SdjA on SdeB and SdeC resembles that of SidJ; we therefore examined whether the activity of SdjA against the mART activity of SdeB (SdeC) requires CaM. Reactions involving members of the SidE family, SdjA, and glutamate with or without CaM were allowed to proceed for 2 h at 37°C, and then the activity of SidE family proteins was tested by adding a cocktail that allows them to ubiquitinate Rab33b. In reactions that involved SdeA, SdjA together with CaM did not detectably affect its ubiquitin ligase activity. In contrast, the activity of SdeB or SdeC was inhibited by SdjA in a CaM-dependent manner, which is consistent with results from a recent report (47). The inhibitory effect against SidE was detectable but was not as robust as that seen with SdeB or SdeC (Fig. 4A). Thus, similar to SidJ, the glutamylase activity of SdjA against SdeB and SdeC requires the cofactor CaM.
Consistent with the results from measuring its inhibitory effects on the ubiquitin ligase activity, in reactions using [14C]glutamate, we detected [14C]Glu-labeled SdeB or SdeC by SdjA in a CaM-dependent manner. Under similar reaction conditions, [14C]Glu-labeled SdeA or SidE was not detectable by autoradiograph despite extended exposure time (Fig. 4B).
Mass-spectrometric analysis revealed that SdjA catalyzes the attachment of a glutamate moiety to the first glutamate residue of the ExE element in the mART motifs of SdeB and SdeC. Although SdeB and SdeC differ greatly in length (29, 48), the modified residue in each case is Glu843 (Fig. 4C and Fig. S3), which is also the site modified by SidJ (39–42). Together, these results establish that SdjA inhibits the activity of SdeB and SdeC by glutamylation in a manner similar to that of SidJ.
SdjA is a deglutamylase that reverses the SidJ-induced glutamylation of SdeA.
The inability to detect the inhibitory effect of SdjA against SdeA prompted us to hypothesize that it may synergize with SidJ. Consistent with results from earlier experiments, SidJ but not SdjA effectively blocked the activity of SdeA (Fig. 5A, second lane). Unexpectedly, in samples expressing both SidJ and SdjA, we observed robust SdeA-induced ubiquitination in multiple independent experiments despite normal SidJ expression (Fig. 5A, third lane).
In light of our earlier finding that the two highly similar proteins, MavC and MvcA, possess completely opposite biochemical activity to regulate the activity of the E2 ubiquitin conjugation enzyme UBE2N (27, 35), we considered the possibility that SdjA inhibits the activity of SidJ, probably by reversing the modification on SdeA. To test this hypothesis, we purified glutamylated SdeA (Glu-SdeA) and used the restoration of its ubiquitin ligase activity to measure the effect of SdjA. Because recombinant SdjA expressed in Escherichia coli tended to be degraded and was not homogenous, we purified full-length SdjA coexpressed with CaM, which allowed us to obtain homogenous SdjA in complex with the cofactor. Unexpectedly, incubation of the SdjA-CaM complex with Glu-SdeA did not restore its ubiquitin ligase activity (Fig. S4, third lane). However, in reactions using a degradation product of SdjA with a molecular weight of approximately 70 kDa obtained from an E. coli strain that did not express CaM, SdeA activity became detectable (Fig. S4, fourth lane), suggesting potential deglutamylation by this fragment of SdjA.
Next, we constructed several truncation mutants of SdjA and tested their deglutamylase activity. A fragment of SdjA that spans residues 251 to 807 (SdjA251–807) expressed in an E. coli strain without CaM was found to effectively restore the ligase activity of Glu-SdeA (Fig. 5B, bottom, third lane). Furthermore, incubation of SdjA251–807 with inactive glutamylated SdeB, SdeC, or SidE also led to restoration of their activity (Fig. 5B). In contrast, neither SidJ nor its N-terminal truncated mutant exhibited detectable deglutamylase activity when incubated with these proteins (Fig. S5), suggesting that the deglutamylase activity is specific to SdjA.
To further validate the deglutamylase activity of SdjA, we prepared glutamylated SdeA with [14C]Glu and used it in a subsequent assay. Incubation of [14C]Glu-SdeA with glutathione S-transferase (GST)-tagged SdjA37–782 (also containing degradation forms of SdjA) led to removal of [14C]Glu from modified SdeA in a dose-dependent manner. Consistent with results from the activity-based assay, CaM is not required for the deglutamylase activity (Fig. 5C).
Similar to SidJ, glutamylation by SdjA requires the pseudokinase domain involved in ATP hydrolysis to activate the target glutamate by acyl adenylation (47). We attempted to separate the two activities of SdjA by replacing Asp480 and Asp483 with alanine, a manipulation known to abolish its glutamylase activity (47). This mutant retained the ability to deglutamylate Glu-SdeA (Fig. 5D). Furthermore, in line with the observation that CaM is not required for the deglutamylase activity, mutations that eliminate the IQ motif responsible for binding CaM did not impact its ability to remove glutamate from Glu-SdeA (Fig. 5D). Thus, the glutamylase and deglutamylase activities of SdjA are independent, and each is likely catalyzed by a unique catalytic center.
The deglutamylase activity of SdjA impacts the intracellular life cycle of L. pneumophila.
Next, we examined the effects of the deglutamylase activity of SdjA on L. pneumophila infection. Expression of CaM in the wild-type strain abolished the activity of the SidE family, and ubiquitination of Rab33b in cells infected with this strain became undetectable (Fig. 6A, top, fourth lane). If SdjA can counteract the activity of SidJ, overexpression of this deglutamylase in this strain should restore Rab33b ubiquitination. Indeed, introducing a plasmid expressing SdjA into strain Lp02(pCaM) led to detectable Rab33b ubiquitination in infected cells (Fig. 6A, top, fifth lane). Expression of CaM and/or SdjA from multicopy plasmids did not interfere with the expression or translocation of endogenous SdeA and SidJ (Fig. 6A, middle and bottom), suggesting that Rab33b ubiquitination occurred in cells infected with strain Lp02(pCaM, pSdjA) is caused by increased activity of SdeA.
One function of SidEs during L. pneumophila infection is to recruit and modify the ER protein RTN4 by phosphoribosyl ubiquitination (32). We examined how SdjA impacts this phenotype by examining the association of RTN4 with the LCV formed by these L. pneumophila strains. Approximately 60% of the vacuoles harboring the wild-type strain stained positive for RTN4. Such recruitment was abolished by deleting members of the sidE family, which can be fully complemented by expressing SdeA from a plasmid (Fig. 6B). Akin to its inhibition of Rab33b ubiquitination (Fig. 1E), expression of CaM in the wild-type strain abolished its ability to recruit RTN4 (Fig. 6B), indicating inactivation of SidEs in bacterial cells by this cofactor. Importantly, in cells infected with strain Lp02(pCaM, pSdjA), recruitment of RTN4 by the bacterial phagosome significantly increased (Fig. 6B). These results suggest that SdjA restores the activity of SdeA, leading to the recruitment of RTN4 to the LCV.
Finally, whereas expression of CaM in the wild-type of L. pneumophila strain caused significant defects in intracellular replication, coexpression of SdjA in this strain markedly restored bacterial virulence, implying that SdjA alleviates the inhibitory effects imposed by SidJ-induced glutamylation of some members of the SidE family, particularly SdeA (Fig. 6C).
DISCUSSION
The SidE effector family of L. pneumophila is required for optimal virulence in amoeba hosts (45, 48). These proteins catalyze phosphoribosyl ubiquitination of a large cohort of host proteins, including many that are essential for cell viability (26, 32, 37, 38). To prevent their potential excessive damage to host physiology, the bacterium has evolved two distinct mechanisms to regulate the activity of SidEs: first, the use of the phosphodiesterases DupA and DupB to specifically remove phosphoribosyl ubiquitin from modified proteins (37, 38), and second, the inhibition of the ADP-ribosyltransferase activity by the calmodulin-dependent glutamylase SidJ (39–42). Our results herein demonstrate that SdjA, the homolog of SidJ, is a bifunctional protein that distinctly regulates the activity of members of the SidE family.
SdjA satisfies the criteria for a CaM-dependent glutamylase against SdeB and SdeC, including effective suppression of their yeast toxicity, strong inhibition of their ubiquitin ligase activity in mammalian cells, the ability to inactivate their ADP-ribosyltransferase activity in ubiquitin activation, the ability to covalently attach glutamate moieties to the first glutamate residues of the ExE motif in their mART domain, and finally, the ability to inhibit substrate ubiquitination induced by SdeB and SdeC in cells infected with L. pneumophila (Fig. 1 and 4). To some extent, SdjA and SidJ are functionally redundant in their activities toward SdeB and SdeC.
The most unexpected activity of SdjA is its ability to antagonize the inhibitory effects of SidJ against SdeA. Several lines of evidence suggest that SdjA is also a deglutamylase that functions to remove glutamate from Glu-SdeA. First, SdjA effectively alleviated SidJ-mediated inhibition of SdeA activity in mammalian cells. Second, incubation of recombinant SdjA251–807 with inactive Glu-SdeA restored its ubiquitin ligase activity. Third, GST-tagged SdjA containing its degradation forms effectively removed radioactivity from [14C]Glu-SdeA produced by SidJ (Fig. 5). Finally, overexpression of SdjA appeared to restore the ubiquitin ligase activity of SdeA in a wild-type L. pneumophila strain expressing CaM (Fig. 6).
The deglutamylase activity of SdjA appears to be regulated by some yet-unrecognized mechanisms. Whereas full-length SdjA in complex with CaM expressed in E. coli did not have detectable deglutamylase activity against Glu-SdeA, such activity became robust in experiments in which SdjA tended to be degraded (Fig. 5; Fig. S4). It is likely that the deglutamylase activity seen in bacterial or mammalian cells in which SdjA was expressed either by its endogenous promoter or by transfection results from a fragment derived from spontaneous degradation. Apparently, based on the present results, the activity associated with SdjA expressed in cells is specific for SdeA. These results differ from those of SdjA251–807, a truncation mutant that indiscriminately removed glutamate from all members of the SidE family in biochemical reactions (Fig. 5B). A recent study revealed that the N-terminal domain (NTD) of SdjA is involved in recognizing members of the SidE family; replacement of the helix-turn-helix motif (HTH) in SdjA with that from SidJ made it able to modify SdeA by glutamylation (47). This HTH motif, and even the NTD, is absent in our truncation mutant SdjA251–807, which may explain its indiscriminate deglutamylation activity toward all members of the SidE family. However, it remains to be investigated how SdjA recognizes SidE family proteins in the absence of the NTD. For the in cellulo deglutamylase activity of SdjA, we speculate that SdjA may work with some yet-unidentified factors in eukaryotic cells to achieve its specificity toward SdeA. Another possibility is that the deglutamylase activity of SdjA does come from a degraded form of SdjA, yet the glutamylation activity of full-length SdjA toward SdeB and SdeC is so strong that it overwhelms the deglutamylation activity of the degraded form of SdjA in cells. The dual activity of SdjA adds further complexity to the regulation of the SidEs. In addition to the reversal of modified substrates by DupA and DupB (37, 38), the ubiquitin ligase activity is inhibited by SidJ (39–42) and for some members by both SidJ and SdjA, with the latter being able to alleviate the inhibitory effects of SidJ on SdeA (Fig. 7).
The dual activity of SdjA is reminiscent of MavC, the transglutaminase that under normal conditions induces protein cross-linking between ubiquitin and the E2 enzyme UBE2N (27). However, this enzyme also hydrolyzed its own product into UBE2N and Ub when high concentrations of protein were used (49, 50). MavC and MvcA, the enzyme that reverses the modification, are structurally similar with an identical catalytic center (34, 35, 49, 50). It has been proposed that the same catalytic mechanism is used for both the forward and reverse reactions and that it is the affinity between the product and the enzyme that dictates the outcome of the reaction (50). The removal of the glutamate moiety from Glu-SdeA requires the cleavage of an isopeptide bond. However, our attempts to identify residues in SdjA251–807 critical for its deglutamylase activity have not been successful. Notably, SdjA251–807 has completely lost the glutamylation activity against all members of the SidE family (Fig. S6), which is consistent with the notion that the NTD of SidJ/SdjA is essential for its glutamylation activity. Together with the observation that a SdjA mutant defective in the glutamylase activity is still active in deglutamylation (Fig. 5D), these results suggest that the two activities are separate and distinct, at least under conditions used for our biochemical reactions. Moreover, while CaM is essential for the glutamylation activity of SdjA, it is dispensable for the deglutamylation activity of SdjA. Future structure-based analysis will be instrumental in determining the exact catalytic mechanism for the peptidase activity of SdjA. Such comparative analysis may reveal how such subtle variations in structures are translated into drastic differences in functionality, which will extend our understanding of not only the relationship between structure and function but also protein evolution.
MATERIALS AND METHODS
Bacterial strains, plasmids, and cell culture.
E. coli strains DH5α and XL1-Blue were used for molecular cloning, and strain BL21(DE3) was used for recombinant protein production. E. coli was grown on LB agar plates or in LB medium at 37°C. To maintain plasmids in E. coli, antibiotics were used at the following concentrations: ampicillin, 100 μg/ml; kanamycin, 30 μg/ml. All L. pneumophila strains were derived from the Philadelphia 1 strain Lp02 and the dotA mutant strain Lp03 and are listed in Table S1 (51). L. pneumophila was cultured in liquid N-(2-acetamido)-2-aminoethanesulfonic acid-buffered yeast extract medium (AYE) or on solid charcoal-buffered yeast extract medium (CYE). When necessary, thymidine was added to a final concentration of 0.2 g/ml. Plasmids derived from pZL507 (52) were maintained in L. pneumophila by thymidine autotrophy. Gene deletion in L. pneumophila was carried out as described previously (43). Additional methods are available in the supplemental material.
ACKNOWLEDGMENTS
We thank Shaohua Wang for plasmids, Victor Roman for making pZLQ-Flag, and Karl Weitz and Ronald Moore for assistance in mass spectrometry analysis.
This work was supported in part by National Institutes of Health grant R01AI127465 (Z.-Q.L.) and National Natural Science Foundation of China 31822012 (Y.F.). Mass spectrometry analysis was performed in the Environmental Molecular Sciences Laboratory, a U.S. Department of Energy (DOE) national scientific user facility at Pacific Northwest National Laboratory (PNNL) in Richland, WA. Battelle operates PNNL for the DOE under contract DE-AC05-76RLO01830.
We declare that no competing interests exist.
L.S., Z.-Q.L., and Y.F. conceived the projects. L.S., Y. Xie, C.L., L.W., Y.Z., C.H., J.Y., J.L., X.L., Y. Xiu, and H.L. performed the experiments. M.G. and E.S.N. performed the mass-spectrometric analysis. L.S., Y.F., E.S.N., and Z.-Q.L. analyzed data. Z.-Q.L. drafted the first version of the manuscript, and Z.-Q.L. revised the manuscript with input from all authors.
Footnotes
This article is a direct contribution from Zhao-Qing Luo, a Fellow of the American Academy of Microbiology, who arranged for and secured reviews by Tomoko Kubori, Gifu University, and Elizabeth Hartland, Hudson Institute of Medical Research.
Citation Song L, Xie Y, Li C, Wang L, He C, Zhang Y, Yuan J, Luo J, Liu X, Xiu Y, Li H, Gritsenko M, Nakayasu ES, Feng Y, Luo Z-Q. 2021. The Legionella effector SdjA is a bifunctional enzyme that distinctly regulates phosphoribosyl ubiquitination. mBio 12:e02316-21. https://doi.org/10.1128/mBio.02316-21.
Contributor Information
Lei Song, Email: lsong@jlu.edu.cn.
Yue Feng, Email: fengyue@mail.buct.edu.cn.
Zhao-Qing Luo, Email: luoz@purdue.edu.
Nancy E. Freitag, University of Illinois at Chicago
REFERENCES
- 1.Appelt S, Heuner K. 2017. The flagellar regulon of Legionella—a review. Front Cell Infect Microbiol 7:454. doi: 10.3389/fcimb.2017.00454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Das C, Mokashi C, Mande SS, Saini S. 2018. Dynamics and control of flagella assembly in Salmonella typhimurium. Front Cell Infect Microbiol 8:36. doi: 10.3389/fcimb.2018.00036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Broz P, Monack DM. 2011. Molecular mechanisms of inflammasome activation during microbial infections. Immunol Rev 243:174–190. doi: 10.1111/j.1600-065X.2011.01041.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Kubori T, Galan JE. 2003. Temporal regulation of salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115:333–342. doi: 10.1016/s0092-8674(03)00849-3. [DOI] [PubMed] [Google Scholar]
- 5.Qiu J, Luo ZQ. 2017. Legionella and Coxiella effectors: strength in diversity and activity. Nat Rev Microbiol 15:591–605. doi: 10.1038/nrmicro.2017.67. [DOI] [PubMed] [Google Scholar]
- 6.Arasaki K, Toomre DK, Roy CR. 2012. The Legionella pneumophila effector DrrA is sufficient to stimulate SNARE-dependent membrane fusion. Cell Host Microbe 11:46–57. doi: 10.1016/j.chom.2011.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Machner MP, Isberg RR. 2006. Targeting of host Rab GTPase function by the intravacuolar pathogen Legionella pneumophila. Dev Cell 11:47–56. doi: 10.1016/j.devcel.2006.05.013. [DOI] [PubMed] [Google Scholar]
- 8.Ingmundson A, Delprato A, Lambright DG, Roy CR. 2007. Legionella pneumophila proteins that regulate Rab1 membrane cycling. Nature 450:365–369. doi: 10.1038/nature06336. [DOI] [PubMed] [Google Scholar]
- 9.Mumberg D, Muller R, Funk M. 1995. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 156:119–122. doi: 10.1016/0378-1119(95)00037-7. [DOI] [PubMed] [Google Scholar]
- 10.Nagai H, Kagan JC, Zhu X, Kahn RA, Roy CR. 2002. A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science 295:679–682. doi: 10.1126/science.1067025. [DOI] [PubMed] [Google Scholar]
- 11.Finsel I, Ragaz C, Hoffmann C, Harrison CF, Weber S, van Rahden VA, Johannes L, Hilbi H. 2013. The Legionella effector RidL inhibits retrograde trafficking to promote intracellular replication. Cell Host Microbe 14:38–50. doi: 10.1016/j.chom.2013.06.001. [DOI] [PubMed] [Google Scholar]
- 12.Yao J, Yang F, Sun X, Wang S, Gan N, Liu Q, Liu D, Zhang X, Niu D, Wei Y, Ma C, Luo ZQ, Sun Q, Jia D. 2018. Mechanism of inhibition of retromer transport by the bacterial effector RidL. Proc Natl Acad Sci USA 115:E1446–E1454. doi: 10.1073/pnas.1717383115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Gaspar AH, Machner MP. 2014. VipD is a Rab5-activated phospholipase A1 that protects Legionella pneumophila from endosomal fusion. Proc Natl Acad Sci USA 111:4560–4565. doi: 10.1073/pnas.1316376111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Franco IS, Shohdy N, Shuman HA. 2012. The Legionella pneumophila effector VipA is an actin nucleator that alters host cell organelle trafficking. PLoS Pathog 8:e1002546. doi: 10.1371/journal.ppat.1002546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Liu Y, Zhu W, Tan Y, Nakayasu ES, Staiger CJ, Luo ZQ. 2017. A Legionella effector disrupts host cytoskeletal structure by cleaving actin. PLoS Pathog 13:e1006186. doi: 10.1371/journal.ppat.1006186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.He L, Lin Y, Ge ZH, He SY, Zhao BB, Shen D, He JG, Lu YJ. 2019. The Legionella pneumophila effector WipA disrupts host F-actin polymerisation by hijacking phosphotyrosine signalling. Cell Microbiol 21:e13014. doi: 10.1111/cmi.13014. [DOI] [PubMed] [Google Scholar]
- 17.Michard C, Sperandio D, Bailo N, Pizarro-Cerda J, LeClaire L, Chadeau-Argaud E, Pombo-Gregoire I, Hervet E, Vianney A, Gilbert C, Faure M, Cossart P, Doublet P. 2015. The Legionella kinase LegK2 targets the ARP2/3 complex to inhibit actin nucleation on phagosomes and allow bacterial evasion of the late endocytic pathway. mBio 6:e00354-15. doi: 10.1128/mBio.00354-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Li G, Liu H, Luo ZQ, Qiu J. 2021. Modulation of phagosome phosphoinositide dynamics by a Legionella phosphoinositide 3-kinase. EMBO Rep 22:e51163. doi: 10.15252/embr.202051163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hsieh T-S, Lopez VA, Black MH, Osinski A, Pawłowski K, Tomchick DR, Liou J, Tagliabracci VS. 2021. Dynamic remodeling of host membranes by self-organizing bacterial effectors. Science 372:935–941. doi: 10.1126/science.aay8118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Dong N, Niu M, Hu L, Yao Q, Zhou R, Shao F. 2016. Modulation of membrane phosphoinositide dynamics by the phosphatidylinositide 4-kinase activity of the Legionella LepB effector. Nat Microbiol 2:16236. doi: 10.1038/nmicrobiol.2016.236. [DOI] [PubMed] [Google Scholar]
- 21.Hsu F, Zhu W, Brennan L, Tao L, Luo ZQ, Mao Y. 2012. Structural basis for substrate recognition by a unique Legionella phosphoinositide phosphatase. Proc Natl Acad Sci USA 109:13567–13572. doi: 10.1073/pnas.1207903109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Weber SS, Ragaz C, Reus K, Nyfeler Y, Hilbi H. 2006. Legionella pneumophila exploits PI(4)P to anchor secreted effector proteins to the replicative vacuole. PLoS Pathog 2:e46. doi: 10.1371/journal.ppat.0020046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Brombacher E, Urwyler S, Ragaz C, Weber SS, Kami K, Overduin M, Hilbi H. 2009. Rab1 guanine nucleotide exchange factor SidM is a major phosphatidylinositol 4-phosphate-binding effector protein of Legionella pneumophila. J Biol Chem 284:4846–4856. doi: 10.1074/jbc.M807505200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kagan JC, Roy CR. 2002. Legionella phagosomes intercept vesicular traffic from endoplasmic reticulum exit sites. Nat Cell Biol 4:945–954. doi: 10.1038/ncb883. [DOI] [PubMed] [Google Scholar]
- 25.Qiu J, Luo ZQ. 2017. Hijacking of the host ubiquitin network by Legionella pneumophila. Front Cell Infect Microbiol 7:487. doi: 10.3389/fcimb.2017.00487. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Qiu J, Sheedlo MJ, Yu K, Tan Y, Nakayasu ES, Das C, Liu X, Luo ZQ. 2016. Ubiquitination independent of E1 and E2 enzymes by bacterial effectors. Nature 533:120–124. doi: 10.1038/nature17657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Gan N, Nakayasu ES, Hollenbeck PJ, Luo ZQ. 2019. Legionella pneumophila inhibits immune signalling via MavC-mediated transglutaminase-induced ubiquitination of UBE2N. Nat Microbiol 4:134–143. doi: 10.1038/s41564-018-0282-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kitao T, Nagai H, Kubori T. 2020. Divergence of Legionella effectors reversing conventional and unconventional ubiquitination. Front Cell Infect Microbiol 10:448. doi: 10.3389/fcimb.2020.00448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Luo ZQ, Isberg RR. 2004. Multiple substrates of the Legionella pneumophila Dot/Icm system identified by interbacterial protein transfer. Proc Natl Acad Sci USA 101:841–846. doi: 10.1073/pnas.0304916101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hsu F, Luo X, Qiu J, Teng YB, Jin J, Smolka MB, Luo ZQ, Mao Y. 2014. The Legionella effector SidC defines a unique family of ubiquitin ligases important for bacterial phagosomal remodeling. Proc Natl Acad Sci USA 111:10538–10543. doi: 10.1073/pnas.1402605111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Jeng EE, Bhadkamkar V, Ibe NU, Gause H, Jiang L, Chan J, Jian R, Jimenez-Morales D, Stevenson E, Krogan NJ, Swaney DL, Snyder MP, Mukherjee S, Bassik MC. 2019. Systematic identification of host cell regulators of Legionella pneumophila pathogenesis using a genome-wide CRISPR screen. Cell Host Microbe 26:551–563.E6. doi: 10.1016/j.chom.2019.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kotewicz KM, Ramabhadran V, Sjoblom N, Vogel JP, Haenssler E, Zhang M, Behringer J, Scheck RA, Isberg RR. 2017. A single Legionella effector catalyzes a multistep ubiquitination pathway to rearrange tubular endoplasmic reticulum for replication. Cell Host Microbe 21:169–181. doi: 10.1016/j.chom.2016.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kawabata M, Matsuo H, Koito T, Murata M, Kubori T, Nagai H, Tagaya M, Arasaki K. 2021. Legionella hijacks the host Golgi-to-ER retrograde pathway for the association of Legionella-containing vacuole with the ER. PLoS Pathog 17:e1009437. doi: 10.1371/journal.ppat.1009437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Valleau D, Quaile AT, Cui H, Xu X, Evdokimova E, Chang C, Cuff ME, Urbanus ML, Houliston S, Arrowsmith CH, Ensminger AW, Savchenko A. 2018. Discovery of ubiquitin deamidases in the pathogenic arsenal of Legionella pneumophila. Cell Rep 23:568–583. doi: 10.1016/j.celrep.2018.03.060. [DOI] [PubMed] [Google Scholar]
- 35.Gan N, Guan H, Huang Y, Yu T, Fu J, Nakayasu ES, Puvar K, Das C, Wang D, Ouyang S, Luo ZQ. 2020. Legionella pneumophila regulates the activity of UBE2N by deamidase-mediated deubiquitination. EMBO J 39:e102806. doi: 10.15252/embj.2019102806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Bhogaraju S, Kalayil S, Liu Y, Bonn F, Colby T, Matic I, Dikic I. 2016. Phosphoribosylation of ubiquitin promotes serine ubiquitination and impairs conventional ubiquitination. Cell 167:1636–1649.E13. doi: 10.1016/j.cell.2016.11.019. [DOI] [PubMed] [Google Scholar]
- 37.Wan M, Sulpizio AG, Akturk A, Beck WHJ, Lanz M, Faca VM, Smolka MB, Vogel JP, Mao Y. 2019. Deubiquitination of phosphoribosyl-ubiquitin conjugates by phosphodiesterase-domain-containing Legionella effectors. Proc Natl Acad Sci USA 116:23518–23526. doi: 10.1073/pnas.1916287116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Shin D, Mukherjee R, Liu Y, Gonzalez A, Bonn F, Liu Y, Rogov VV, Heinz M, Stolz A, Hummer G, Dotsch V, Luo ZQ, Bhogaraju S, Dikic I. 2020. Regulation of phosphoribosyl-linked serine ubiquitination by deubiquitinases DupA and DupB. Mol Cell 77:164–179.E6. doi: 10.1016/j.molcel.2019.10.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Bhogaraju S, Bonn F, Mukherjee R, Adams M, Pfleiderer MM, Galej WP, Matkovic V, Lopez-Mosqueda J, Kalayil S, Shin D, Dikic I. 2019. Inhibition of bacterial ubiquitin ligases by SidJ-calmodulin catalysed glutamylation. Nature 572:382–386. doi: 10.1038/s41586-019-1440-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Black MH, Osinski A, Gradowski M, Servage KA, Pawłowski K, Tomchick DR, Tagliabracci VS. 2019. Bacterial pseudokinase catalyzes protein polyglutamylation to inhibit the SidE-family ubiquitin ligases. Science 364:787–792. doi: 10.1126/science.aaw7446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Gan N, Zhen X, Liu Y, Xu X, He C, Qiu J, Liu Y, Fujimoto GM, Nakayasu ES, Zhou B, Zhao L, Puvar K, Das C, Ouyang S, Luo ZQ. 2019. Regulation of phosphoribosyl ubiquitination by a calmodulin-dependent glutamylase. Nature 572:387–391. doi: 10.1038/s41586-019-1439-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Sulpizio A, Minelli ME, Wan M, Burrowes PD, Wu X, Sanford EJ, Shin JH, Williams BC, Goldberg ML, Smolka MB, Mao Y. 2019. Protein polyglutamylation catalyzed by the bacterial calmodulin-dependent pseudokinase SidJ. Elife 8:51162. doi: 10.7554/eLife.51162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Liu Y, Luo ZQ. 2007. The Legionella pneumophila effector SidJ is required for efficient recruitment of endoplasmic reticulum proteins to the bacterial phagosome. Infect Immun 75:592–603. doi: 10.1128/IAI.01278-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Qiu J, Yu K, Fei X, Liu Y, Nakayasu ES, Piehowski PD, Shaw JB, Puvar K, Das C, Liu X, Luo ZQ. 2017. A unique deubiquitinase that deconjugates phosphoribosyl-linked protein ubiquitination. Cell Res 27:865–881. doi: 10.1038/cr.2017.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Jeong KC, Sexton JA, Vogel JP. 2015. Spatiotemporal regulation of a Legionella pneumophila T4SS substrate by the metaeffector SidJ. PLoS Pathog 11:e1004695. doi: 10.1371/journal.ppat.1004695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Havey JC, Roy CR. 2015. Toxicity and SidJ-mediated suppression of toxicity require distinct regions in the SidE family of Legionella pneumophila effectors. Infect Immun 83:3506–3514. doi: 10.1128/IAI.00497-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Osinski A, Black MH, Pawłowski K, Chen Z, Li Y, Tagliabracci VS. 17 August 2021. Structural and mechanistic basis for protein glutamylation by the kinase fold. Mol Cell doi: 10.1016/j.molcel.2021.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Bardill JP, Miller JL, Vogel JP. 2005. IcmS-dependent translocation of SdeA into macrophages by the Legionella pneumophila type IV secretion system. Mol Microbiol 56:90–103. doi: 10.1111/j.1365-2958.2005.04539.x. [DOI] [PubMed] [Google Scholar]
- 49.Mu Y, Wang Y, Huang Y, Li D, Han Y, Chang M, Fu J, Xie Y, Ren J, Wang H, Zhang Y, Luo ZQ, Feng Y. 2020. Structural insights into the mechanism and inhibition of transglutaminase-induced ubiquitination by the Legionella effector MavC. Nat Commun 11:1774. doi: 10.1038/s41467-020-15645-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Guan H, Fu J, Yu T, Wang ZX, Gan N, Huang Y, Perculija V, Li Y, Luo ZQ, Ouyang S. 2020. Molecular basis of ubiquitination catalyzed by the bacterial transglutaminase MavC. Adv Sci (Weinh) 7:2000871. doi: 10.1002/advs.202000871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Berger KH, Isberg RR. 1993. Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila. Mol Microbiol 7:7–19. doi: 10.1111/j.1365-2958.1993.tb01092.x. [DOI] [PubMed] [Google Scholar]
- 52.Xu L, Shen X, Bryan A, Banga S, Swanson MS, Luo ZQ. 2010. Inhibition of host vacuolar H+-ATPase activity by a Legionella pneumophila effector. PLoS Pathog 6:e1000822. doi: 10.1371/journal.ppat.1000822. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.